Close
LCS Announces 2024 Chef of the Year Finalists Jun 3, 2024 08:23AM

Des Moines, IA, June 03, 2024 (GLOBE NEWSWIRE) -- LCS has announced the finalists for the 2024 LCS “Chef of the Year” competition. The annual competition celebrates the hospitality and culinary talents of chefs in senior living communities owned and managed by Life Care Services. Chef of the Year finalists were selected by a steering committee that reviewed applicant recipes, plated dishes, and videos highlighting work in their respective communities. 

Five... (continue reading...)


Form 8.3 - Irish Residential Properties REIT plc Jun 3, 2024 08:20AM

                                                        FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)State Street Global Advisors & AffiliatesCompany dealt inIrish Residential Properties REIT plcClass of... (continue reading...)
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial Jun 3, 2024 08:20AM

The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k) submission

BRAINTREE, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces that it has received the U.S. Food and Drug Administration’s (“FDA”)... (continue reading...)


Report on transactions of executives and related parties in ROCKWOOL A/S shares Jun 3, 2024 08:17AM

Company announcementfor ROCKWOOL A/SRelease no. 30 – 2024to Nasdaq Copenhagen        

3 June 2024

Report on transactions of executives and related parties in ROCKWOOL A/S shares

ROCKWOOL A/S has received and hereby provides notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in ROCKWOOL A/S made by persons discharging managerial responsibilities and/or persons closely related with them.

1 Details... (continue reading...)


Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial Jun 3, 2024 08:15AM

Company plans to release topline results from “lead-in” patients (n=5) imminently

THE WOODLANDS, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced it has received Ethics Committee approval of the protocol amendment for its... (continue reading...)


More Globe Newswire

View Older Stories

Jun 3, 2024 08:14AM AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
Jun 3, 2024 08:14AM AUROBAC THERAPEUTICS Presents its R&D Strategy & Pipeline and Announces New Development Program in Partnership with Boehringer Ingelheim
Jun 3, 2024 08:11AM Molecular Templates, Inc. Provides Interim Update
Jun 3, 2024 08:10AM Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
Jun 3, 2024 08:09AM Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL)
Jun 3, 2024 08:09AM Coherent Appoints Jim Anderson as Chief Executive Officer
Jun 3, 2024 08:07AM Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
Jun 3, 2024 08:05AM NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
Jun 3, 2024 08:05AM InnovAge PACE Recertified as a Great Place to Work
Jun 3, 2024 08:04AM Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
Jun 3, 2024 08:02AM Ready Capital to Present at Nareit’s REITweek 2024
Jun 3, 2024 08:02AM Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
Jun 3, 2024 08:00AM AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
Jun 3, 2024 08:01AM Texas Must Close Primary Elections
Jun 3, 2024 08:00AM Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeti
Jun 3, 2024 08:01AM Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
Jun 3, 2024 08:00AM Genesis Offers New Tools and Incentives to Financial Industry Software Developers
Jun 3, 2024 08:00AM Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
Jun 3, 2024 08:00AM BriaCell Presents Clinical Efficacy Data at ASCO 2024
Jun 3, 2024 08:00AM Tonix Pharmaceuticals Presented New Data on Tonmya™ Suggesting Activity for Improvement in Fibromyalgia-Associated Depression Severity in an Oral Presentation at ASCP Annual Meeting
Jun 3, 2024 08:00AM Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024
Jun 3, 2024 08:00AM PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
Jun 3, 2024 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
Jun 3, 2024 08:00AM Enphase Energy Launches IQ Battery 5P in Canada
Jun 3, 2024 08:00AM KULR Announces Expiration of SEPA Facility and Compliance with NYSE Guidelines on Audit Opinion Disclosure
Jun 3, 2024 08:00AM Apogee Minerals Announces Appointment of New Director
Jun 3, 2024 08:00AM ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
Jun 3, 2024 08:00AM ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
Jun 3, 2024 08:00AM Abacus Life and AIMCOR Announce New National Distribution Agreement
Jun 3, 2024 08:00AM Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 3, 2024 08:00AM Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
Jun 3, 2024 08:00AM Core Molding Technologies to Present and Host 1x1 Meetings at the 14th Annual East Coast IDEAS Conference on June 13, 2024
Jun 3, 2024 08:00AM Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3, 2024 08:00AM Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3, 2024 08:00AM ConnectWise Research finds 78% of SMBs Concerned a Cyber Attack Could Put Their Organizations Out of Business
Jun 3, 2024 08:00AM Introducing the TimeProvider® XT Extension System for Migrating to a Modern Synchronization and Timing Systems Architecture
Jun 3, 2024 08:00AM DZS Completes NetComm Acquisition
Jun 3, 2024 08:00AM ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases
Jun 3, 2024 08:00AM European Cup Inu: Transforming the Euro 2024 Experience with Innovative Crypto Betting
Jun 3, 2024 08:00AM Syntec Optics (Nasdaq: OPTX) to Participate in the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference
Jun 3, 2024 08:00AM Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer
Jun 3, 2024 08:00AM VCI Global Gives Full Year Guidance After Seeing Revenues Increase Over 145% in 2023
Jun 3, 2024 08:00AM LiveOne to Host Special Investor Webcast to Provide Update on Strategic Partnerships, B2B Pipeline and Addressable Market for all Subsidiaries
Jun 3, 2024 08:00AM The Metals Company Welcomes Prominent Sustainability Strategist Brendan May to its Board of Directors
Jun 3, 2024 08:00AM FangDD Announces Termination Plan for Its ADR Facility, and the Plan to Hold an Extraordinary General Meeting of Shareholders
Jun 3, 2024 08:00AM Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
Jun 3, 2024 08:00AM Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
Jun 3, 2024 08:00AM Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
Jun 3, 2024 08:00AM Getty Realty Corp. Publishes 2024 Corporate Responsibility Report
Jun 3, 2024 08:00AM 23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
View Older Stories